Johnson&Johnson (J&J) Signs a Research Collaboration with Apple for Atrial Fibrillation (AFib)

 Johnson&Johnson (J&J) Signs a Research Collaboration with Apple for Atrial Fibrillation (AFib)

Johnson&Johnson (J&J) Signs a Research Collaboration with Apple for Atrial Fibrillation (AFib)

Shots:

  • J&J and Apple collaborate to initiate a heart health program in combination with J&J’s app & Apple Watch’s irregular rhythm notifications and ECG app, for developing methods in detecting and improving QoL for patients with AFib
  • The focus of the collaboration is to measure the results of health program with rhythm notifications on Apple Watch including prevention of strokes & evaluating the effects of medication adherence program using J&J’s app
  • In H2’19, the heart health program will be launched enrolling patients aged 65 years or older with AFib in the US

Click here to read full press release/ article | Ref: J&J | Image: Market watch

Shiwani Sharma

Shiwani Sharma is a Senior Editor at PharmaShots. She has in-depth knowledge of lifesciences industry including pharma and biotech sectors. She also covers news in field of Digital Health, Medtech and regulatory approvals from the US FDA, EU, and other global regulatory bodies in the industry. Additionally, she also writes Whitepapers, analysis reports, blogs on pharma and biotech industry. She is graduate in Biotechnology. She can be contacted on shiwani@pharmashots.com

Related post